SERUM AMYLOID A PROTEIN IN AMYLOIDOSIS, RHEUMATIC, AND NEOPLASTIC DISEASES
SERUM AMYLOID A PROTEIN IN AMYLOIDOSIS, RHEUMATIC, AND NEOPLASTIC DISEASES
复制标题
DOI:
10.1002/art.1780220106
复制
发表时间:
1979-01-01
影响因子:
--
通讯作者:
COHEN, AS
中科院分区:
文献类型:
--
作者:
BENSON, MD;COHEN, AS
Serum levels of amyloid protein A (SAA) were elevated in different types of amyloidosis and in rheumatic diseases by radioimmunoassay using 125I-labeled AA and anti-AA. SAA levels were elevated in primary and secondary amyloidosis, but there were highly significant differences between these levels. In hereditary familial amyloid, SAA levels were within normal limits. While the mean SAA level was elevated in persons over 70 yr, the fact that some persons in this age group had normal levels suggested that marked elevation after age 70 may be due to occult inflammatory or neoplastic disease. High SAA levels in patients with rheumatoid arthritis usually correlated with physician evaluation of disease activity and Westergren ESR. SAA levels in patients with systemic lupus erythematosus were lower than those in patients with rheumatoid arthritis, and most patients with degenerative joint disease had normal levels. Very high levels of SAA were found in patients with neoplastic diseases. Patients with carcinoma of the lung and bowel had much higher levels than patients with carcinoma of the breast. Determination of SAA levels may be of value in evaluating different forms of systemic amyloidosis, assessing the activity of rheumatic disease, and screening for occult inflammatory or neoplastic disease.